Results 251 to 260 of about 1,710,125 (310)

Loss of AMBRA1 activates MAPK and angiogenesis signaling pathways in melanoma cells

FEBS Open Bio, EarlyView.
Loss of AMBRA1 in melanoma cells activates multiple oncogenic pathways associated with tumor progression. Transcriptomic and protein network analyses revealed that AMBRA1 depletion enhances MAPK/ERK signaling, angiogenesis, TGF‐β/EMT signaling, and Wnt/axon guidance pathways.
Milad Ibrahim, Marco Corazzari, Iman Osman, Jane Armstrong, Noel Carter   +4 more
wiley   +1 more source

Unveiling the Silent Regulators: Noncoding RNAs in Parasitic Disease Diagnosis and Therapy. [PDF]

J Parasitol Res
Loku Gamage N, Ranasinghe K.
europepmc   +1 more source

Editorial: Circular RNAs: from anomalies to cellular regulators. [PDF]

Front Genet
Barbagallo D, Chianese R, Manfrevola F.
europepmc   +1 more source

Cross-kingdom noncoding RNA regulation facilitates <i>Nosema bombycis</i> proliferation. [PDF]

Eng Microbiol
Zhang P, Deng B, Fang W, Liu F, Chen P, Huang X, Pan M, Dong Z.   +7 more
europepmc   +1 more source

<i>UBA1-CDK16</i>: A female-specific chimeric RNA emerging through evolution and involved in immune regulation. [PDF]

Sci Adv
Shi X, Blackburn L, Singh S, Glowczyk-Gluc M, Tajammal A, Zahra S, Kumar S, Cornelison R, Liang C, Qin F, Liu A, Lin S, Tang Y, Elfman J, Manley T, Bullock T, Haverstick DM, Wu P, Li H.   +18 more
europepmc   +1 more source

Characterizing the circular RNA landscape in phloem sap of Brassica napus. [PDF]

PLoS One
Lühmann KL, Fekete Z, Fernandes R, Kehr J.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Non-coding RNAs in disease: from mechanisms to therapeutics

Nature Reviews Genetics, 2023
Manuela Ferracin, Kinga Nemeth, George Calin   +2 more
exaly   +2 more sources